INS and Hyperglycemia: As for pancreatic cancer, undiagnosed neoplastic proliferation, leading to impaired insulin secretion, could facilitate the development of hyperglycemia; in this case, diabetes could be the first clinical manifestation of cancer, thus producing the reported epidemiological association [11].